Evidence map›Paper›PMID 26789876›Full record

ArticleThe New England journal of medicine2016

Data Sharing.

Dan L Longo, Jeffrey M Drazen

Abstract readComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. A Meta-Analysis ofG3 (Bethesda, Md.) · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. What Have Data Standards Ever Done for Us?Molecular & cellular proteomics : MCP · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Clinical Research Informatics: a Decade-in-Review.Yearbook of medical informatics · 2024
    Review
  19. Article
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Dan L Longo
Jeffrey M Drazen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aerial view of the concept of data sharing is beautiful. What could be better than having high-quality information carefully reexamined for the possibility that new nuggets of useful data are lying there, previously unseen? The potential for leveraging existing results for even more benefit pays appropriate increased tribute to the patients who put themselves at risk to generate the data. The moral imperative to honor their collective sacrifice is the trump card that takes this trick. However, many of us who have actually conducted clinical research, managed clinical studies and data collection and analysis, and curated data sets have . . .

Indexed as

Gene ExpressionAntineoplastic AgentsBiomarkers, TumorCDX2 Transcription FactorColonic NeoplasmsFemaleHomeodomain ProteinsHumansMaleAntineoplastic AgentsBiomarkers, TumorCDX2 protein, humanCDX2 Transcription FactorHomeodomain Proteins

Identifiers

PMID26789876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.